Pesquisa de referências

Capitalizing on precision medicine : how pharmaceutical firms can shape the future of healthcare

Recurso electrónico / electronic resource
Registro MARC
Tag12Valor
LDR  00000cam a22000004b 4500
001  MAP20180008467
003  MAP
005  20180320133022.0
008  180319s2017 usa|||| ||| ||eng d
040  ‎$a‎MAP‎$b‎spa‎$d‎MAP
084  ‎$a‎931
1102 ‎$0‎MAPA20180003615‎$a‎Danner, Stephan
24510‎$a‎Capitalizing on precision medicine ‎$b‎ : how pharmaceutical firms can shape the future of healthcare‎$c‎Stephan Danner, Dr. Thomas Solbach, Mark Ludwig
260  ‎$b‎PricewaterhouseCoopers‎$c‎2018
520  ‎$a‎Precision medicine holds tremendous potential to remake the healthcare industry. By applying a deeper understanding of diseases with richer patient data and advanced analytics, precision medicine can help physicians tailor medicines to the needs of individual patients, rather than by broader populations, leading to better outcomes at potentially lower costs.
650 4‎$0‎MAPA20080606633‎$a‎Industria farmacéutica
650 4‎$0‎MAPA20160013733‎$a‎Salud Digital
650 4‎$0‎MAPA20080586546‎$a‎Nuevas tecnologías
650 4‎$0‎MAPA20090043374‎$a‎Atención sociosanitaria
650 4‎$0‎MAPA20180003806‎$a‎Medicina de precisión
7001 ‎$0‎MAPA20180003622‎$a‎Solbach, Dr. Thomas
7001 ‎$0‎MAPA20080049416‎$a‎Ludwig, Mark
7102 ‎$0‎MAPA20080445652‎$a‎PricewaterhouseCoopers